— Know what they know.
Not Investment Advice

APRE Earnings

Aprea Therapeutics, Inc.
1W: -8.7% 1M: -15.2% 3M: -7.3% YTD: -18.5% 1Y: -52.4% 3Y: -82.7% 5Y: -99.2%
$0.69
-0.03 (-3.94%)
 
Weekly Expected Move ±6.9%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 32 · $8.6M mcap · 11M float · 2.02% daily turnover · Short 44% of daily vol
Last Earnings 2026-08-12
EPS
$-0.07
▲ Beat +60.6%
Revenue
$253K
Est (actual pending)
EPS Beat Streak: 3 quarters
Next Earnings 2026-11-11
EPS Estimate
$-0.07
Range: $-0.08 - $-0.07
Revenue Estimate
$368K
2 analysts

Estimate vs Actual

Earnings Surprise History

15/18
EPS Beats
3/18
Revenue Beats
83%
EPS Beat Rate
17%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-09-10 annual 2026-12-31 $-0.28 $-0.29 ▼ 0.01 $817,000 $817,000
2026-09-10 annual 2030-12-31 $-0.01 $-0.59 ▼ 0.58 $66,647,999 $66,647,999
2026-09-10 quarter 2027-09-30 $-0.07 $-0.08 ▼ 0.02 $1,218,700 $1,218,700
2026-09-10 quarter 2026-09-30 $-0.07 $-0.07 ▼ 0.01 $307,500 $307,500
2026-09-10 annual 2028-12-31 $-0.30 $-0.35 ▼ 0.05 $4,021,499 $4,021,499
2026-09-10 quarter 2027-06-30 $-0.07 $-0.08 ▼ 0.02 $1,025,600 $1,025,600
2026-09-10 annual 2029-12-31 $-0.35 $-0.58 ▼ 0.22 $12,211,000 $12,211,000
2026-09-10 annual 2027-12-31 $-0.27 $-0.29 ▼ 0.02 $2,263,000 $2,263,000
2026-09-10 quarter 2027-03-30 $-0.07 $-0.08 ▼ 0.02 $858,600 $858,600
2026-09-10 quarter 2027-12-30 $-0.07 $-0.09 ▼ 0.02 $1,423,000 $1,423,000
2026-09-10 quarter 2026-12-30 $-0.07 $-0.07 — $368,500 $368,500
2026-08-20 quarter 2026-06-30 $-0.18 $-0.18 — $253,000 $253,000
2026-08-20 annual 2028-12-31 $-0.73 $-0.30 ▲ 0.44 $4,021,499 $4,021,499
2026-08-20 annual 2027-12-31 $-0.66 $-0.27 ▲ 0.39 $2,263,000 $2,263,000
2026-08-20 annual 2026-12-31 $-0.69 $-0.28 ▲ 0.41 $1,070,000 $817,000
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms